Biohit Oyj to distribute Dynex automated ELISA systems with Gastropanel Finnish healthcare company Biohit Oyj and American company Dynex Technology, Inc. The contract gives Biohit Oyj privileges to distribute Dynex automated ELISA systems world-wide, effective immediately. By using this integrated system alternative, small and medium-sized laboratories can perform GastroPanel and cost-effectively easily rx pills . CEO Semi Korpela, Biohit Oyj: ‘Automated systems conserve time and resources, remove human being errors, increase work basic safety and ensure high-quality outcomes.’ Vice President of Product sales & Advertising Duane Steele, Dynex: ‘Dynex is definitely delighted to cooperate with Biohit to include the GastroPanel to your set of validated assays for our systems, additional strengthening Dynex's position as the global marketplace leader in automatic ELISA processing for the clinical market fully.’..
Bio-similar hormone replacement therapy – an alternative solution to hormone replacement therapy Throughout the span of a woman’s life she might encounter many hormone related symptoms or problems, including premenstrual syndrome, hot flashes, unexplained disposition swings, osteoporosis, weight gain and low libido. Several symptoms are due to hormonal imbalances, from menopause often. However, there is absolutely no cause a woman’s life ought to be turned ugly by hormone imbalance. Bio-identical hormone alternative therapy can be an option to the controversial artificial hormone replacement therapy, produced from equine urine.